Erratum to: Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review of Their Basic and Clinical Pharmacology

  • Sanjay Kalra
  • Published 2015 in
    Diabetes therapy : research, treatment and…

Abstract

In Table 3 on page 358 under the heading Dose modifications for Empagliflozin the sentence ‘‘Contraindicated in patients with creatinine clearance \45 ml/min’’ should read ‘‘Stopped in patients with creatinine clearance \45 ml/min’’. Open Access. This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which… (More)
DOI: 10.1007/s13300-015-0095-1

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.